results as at the year 2019. 3. To consider and approve the 2019 financial statements for the year ended 31 December 2019. 4. To consider and approve the non - profit apportionment 5. To acknowledge the

Million Baht 2020 2019 Sales 1,756.01 1,684.73 Cost of Sales 1,475.46 1,586.07 Gross Margin 280.55 98.66 Gain (loss) on exchange rates (23.34) 21.83 Other Incomes 27.64 4.97 Total Revenues 1,783.65 1,711.52

Million Baht 2020 2019 Sales 1,879.42 1,748.29 Cost of Sales 1,570.97 1,636.11 Gross Margin 308.45 112.18 Gain (loss) on exchange rates 101.34 38.44 Other Incomes 10.12 33.76 Total Revenues 1,990.88

period last year, which could be largely attributed to the factors as follows : 1. The company had increased other income from gain on sales of the unused land of Baht 193.65 million. 2. The company had

amount not exceeding 200 MB; totaling to not exceeding 250 MB. In order to expand investment in business concerning healthcare, esthetic, and cosmetic distribution related to core business of the Company

trademark “Wuttisak Clinic” at the amount not exceeding 200 MB; totaling to not exceeding 250 MB. In order to expand investment in business concerning healthcare, esthetic, and cosmetic distribution related

year since the Company recorded THB 61 million from sugar hedging gain while for the same period last year, there is no sugar hedging gain. Therefore the net effect is decrease in other income

40 11 28% 30 50 -20 -40% Distribution costs -90 -70 -20 29% -62 -59 -3 5% Administrative expenses -108 -181 73 -40% -75 -150 75 -50% Finance cost - Interest expenses -11 -11 - - -8 -7 -1 14% Corporate

policy of some distribution channels in domestic to enhance the efficiency of expenses. Such policy made the decrease of revenue but decrease the expenses caused from that distribution channels also. In

-85.04 -31.07% Other Income 11.04 15.67 -4.63 -29.54% 16.13 23.08 -6.95 -30.10% Distribution costs -92.85 -90.66 2.19 2.42% -83.54 -81.80 1.74 2.13% Administrative expenses -149.95 -140.81 9.14 6.49